<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042299/" ref="ordinalpos=2933&amp;ncbi_uid=6244129&amp;link_uid=PMC4042299" image-link="/pmc/articles/PMC4042299/figure/fig3/" class="imagepopup">Figure 3.  From: The role of epigenetics in the biology of multiple myeloma. </a></div><br /><div class="p4l_captionBody">Combination of promoter hypermethylation of tumor suppressor genes acting as inhibitors of cancer pathways as well as abnormal expression of miRNAs contribute to the activation of the cyclin D/CDK pathway, Jak/STAT3 pathway, Wnt/Î²-catenin signaling pathway and disruption of DAPk/p53 interaction. The dark circles above genes and miRNAs indicate DNA methylation and silencing of the respective gene/miRNA.</div></div>